Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
February's Top Marijuana Penny Stocks: High-Growth Potential in a Volatile Market
The U.S. cannabis industry continues to grow, offering significant opportunities for investors. In 2024, the legal cannabis market reached $34 billion in sales. Analysts expect it to surpass $50 billion by 2030 as more states legalize marijuana. Currently, 38 states allow medical cannabis, while 24 states permit recreational use. Recently, lawmakers introduced new federal legalization bills, sparking investor interest. However, marijuana stocks remain volatile, making penny stocks an attractive but risky option. These low-priced stocks can deliver high gains but require careful research. Traders should watch market trends, company fundamentals, and legalization updates.» Mehr auf marijuanastocks.com
Marijuana Penny Stocks to Add to Your Watchlist Today
The U.S. cannabis industry continues to show remarkable growth, with sales projected to reach $41 billion by 2025. This expansion is driven by increasing legalization efforts and rising consumer demand. Notably, over 20 states have legalized recreational cannabis, while more than 30 allow medical use. In recent news, lawmakers are pushing for federal cannabis reform, which could significantly impact the market. Additionally, investor interest in marijuana penny stocks remains high, as these low-cost stocks offer substantial growth potential. Despite their volatility, penny stocks attract traders looking to capitalize on emerging trends in the cannabis sector.» Mehr auf marijuanastocks.com
Could These 3 Marijuana Stocks To Buy Be Worth It?
Most marijuana stocks perform in the market based on certain factors. For starters, if the company is profitable and shows a track record of continuous growth and success, this is more of an organic way to see upward trading. Now, other ways are when a company can release news impactful enough to get sector trading up, even if it's for a short window. For instance, this can be a new dispensary or product or even some type of acquisition. Yet much of the sector is plagued by uncertainty and volatility.» Mehr auf marijuanastocks.com
Unternehmenszahlen
(EUR) | Sep. 2024 | |
---|---|---|
Umsatz | 23,48 Mio | 1,60% |
Bruttoeinkommen | 10,40 Mio | 30,90% |
Nettoeinkommen | −10,58 Mio | 305,62% |
EBITDA | 4,18 Mio | 58,92% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 22,38 Mio€ |
Anzahl Aktien | 310,35 Mio |
52 Wochen-Hoch/Tief | 0,24€ - 0,0606€ |
Dividenden | Nein |
Beta | 3,07 |
KGV (PE Ratio) | −1,01 |
KGWV (PEG Ratio) | 0,02 |
KBV (PB Ratio) | −3,91 |
KUV (PS Ratio) | 0,22 |
Unternehmensprofil
Cansortium Inc. produziert und vertreibt über seine Tochtergesellschaften medizinisches Cannabis in den Vereinigten Staaten. Das Unternehmen ist in den Bereichen Anbau, Verarbeitung, Einzelhandel und Vertrieb tätig. Seine medizinischen Cannabisprodukte werden in Form von oralen Tropfen, Kapseln, Zäpfchen, topischen Produkten, Spritzen, getrockneten Blüten, Prerolls, Patronen und Esswaren angeboten. Das Unternehmen bietet seine Produkte unter dem Markennamen Fluent an. Mit Stand vom 20. August 2021 betrieb es 28 Apotheken. Cansortium Inc. wurde im Jahr 2018 gegründet und hat seinen Hauptsitz in Miami, Florida.
Name | CANSORTIUM INC. Aktie |
CEO | Robert Beasley |
Sitz | Miami, fl USA |
Website | |
Börsengang | |
Mitarbeiter | 0 |
Ticker Symbole
Börse | Symbol |
---|---|
Pnk | CNTMF |
Frankfurt | 2WM.F |
Assets entdecken
Shareholder von CANSORTIUM INC. Aktie investieren auch in folgende Assets